Improvements in CFTR function compared with baseline elexacaftor–tezacaftor–ivacaftor values demonstrate the potential opportunity to restore normal physiology early and prevent development or progression of cystic fibrosis. The gene discussed is CFTR; the disease is cystic fibrosis.